Skip to content

Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests

Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests in Patients Undergoing Endoscopic Endonasal Transsphenoidal Surgery of Pituitary Gland

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02709863
Enrollment
90
Registered
2016-03-16
Start date
2015-10-31
Completion date
2017-02-28
Last updated
2016-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary Adenoma

Brief summary

This study will compare the effects of sevoflurane, desflurane and total intravenous anaesthesia on pulmonary function tests in patients undergoing endoscopic endonasal transsphenoidal surgery of pituitary gland. Participants will be divided into three equal groups. The first group will receive sevoflurane, second grup will receive desflurane and third grup will receive total intravenous anaesthesia. Investigators are also going to evaluate blood gas analysis.

Detailed description

Investigators are going to evaluate forced expiratory volume in 1st Second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, partial pressure of arterial oxygen (PaO2), partial pressure of arterial carbon dioxide (PaCO2), potential of hydrogen (pH), arterial oxygen saturation (SaO2), base excess (BE), bicarbonate (HCO3) and partial pressure of arterial oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio to compare the effects of drugs.

Interventions

DRUGSevoflurane

1-1.5 MAC, inhalation route, during operation

DRUGDesflurane

1-1.5 MAC, inhalation route, during operation

DRUGPropofol

6-10 mg/kg/h, iv infusion, during operation

Sponsors

Istanbul University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* American Society of Anesthesiologists (ASA) score I-II patients

Exclusion criteria

* Significant cardiopulmonary disease, * Diagnosed obstructive or restrictive pulmonary disease, * Patients with chest wall deformities, liver or kidney failure, * Postoperative lack of cooperation

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline FEV1%predicted (no unit)Preoperative baseline, postoperative 1st hour and postoperative 24th hourFEV1 is measured with spirolab III colour liquid-crystal-display medical spirometer. FEV1%predicted is calculated with age, sex, height and weight input by the same equipment.

Secondary

MeasureTime frameDescription
Change from baseline FVC%predicted (no unit)Preoperative baseline, postoperative 1st hour and postoperative 24th hourFVC is measured with spirolab III colour liquid-crystal-display medical spirometer. FVC%predicted is calculated with age, sex, height and weight input by the same equipment.
Change from baseline FEV1/FVC ratio (no units)Preoperative baseline, postoperative 1st hour and postoperative 24th hourFEV1/FVC ratio is calculated by spirolab III colour liquid-crystal-display medical spirometer based on age, sex, height and weight.
Change from baseline PaO2 (mmHg)Preoperative baseline, during the 1st hour of the operation, during the last hour of the operation, postoperative 1st hour and postoperative 24th hourPaO2 is a component of arterial blood gas analysis done with Cobas B221.
Change from baseline pHPreoperative baseline, during the 1st hour of the operation, during the last hour of the operation, postoperative 1st hour and postoperative 24th hourpH is a component of arterial blood gas analysis done with Cobas B221
Change from baseline PaCO2 (mmHg)Preoperative baseline, during the 1st hour of the operation, during the last hour of the operation, postoperative 1st hour and postoperative 24th hourPaCO2 is a component of arterial blood gas analysis done with Cobas B221.
Change from baseline BE (mmol/L)Preoperative baseline, during the 1st hour of the operation, during the last hour of the operation, postoperative 1st hour and postoperative 24th hourBE is a component of arterial blood gas analysis done with Cobas B221
Change from baseline HCO3 (mmol/L)Preoperative baseline, during the 1st hour of the operation, during the last hour of the operation, postoperative 1st hour and postoperative 24th hourHCO3 is a component of arterial blood gas analysis done with Cobas B221
Change from baseline PaO2/FiO2 ratio (no units)Preoperative baseline, during the 1st hour of the operation, during the last hour of the operation, postoperative 1st hour and postoperative 24th hourPaO2/FiO2 ratio is calculated by investigators
Change from baseline SaO2 (%)Preoperative baseline, during the 1st hour of the operation, during the last hour of the operation, postoperative 1st hour and postoperative 24th hourSaO2 is a component of arterial blood gas analysis done with Cobas B221

Countries

Turkey (Türkiye)

Contacts

Primary ContactAbdulvahap Oguz, MD
avahapoguz@gmail.com00905444461924

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026